Deane appointed to lead ALS

Australia-based international laboratory testing and services group ALS has confirmed its chief strategy officer, Malcolm Deane, has succeeded Raj Naran as CEO.

Texas-based Deane has been at ALS in various roles for more than a decade.

The internal appointment comes after a “comprehensive global search and selection process”, according to ALS.

“My focus is to ensure we continue delivering against our strategic FY2027 vision,” Deane said in a company statement.

“ALS is well-positioned to pursue its strong growth agenda, and we will continue to make the necessary investments to further improve the quality and diversity of our portfolio.

“I look forward to sharing our vision in more detail at the release of the FY23 financial results on 29 May 2023.”

ALS has said it aimed to increase last year’s earnings before interest and tax of $400 million to $600 million by 2027.

The company is one of the world’s largest mineral laboratory analysis groups.

ALS shares traded down about 2% today to A$12.64, capitalising the company at $6.12 billion.


Leave a Reply

Not registered? Register Now

Powered By MemberPress WooCommerce Plus Integration